MUC1*targeting CAR T

被引：0
|
作者：
Bamdad, Cynthia Carol
Stewart, Andrew K.
Smagghe, Benoit J.
Deary, Luke T.
Kohler, Victoria L.
Dietz, Jared L.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3330
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3330
引用
收藏
页数：2
相关论文
共 50 条
  • [21] MUC1 as a target for CAR-T therapy in head and neck squamous cell carinoma
    Mei, Zi
    Zhang, Kai
    Lam, Alfred King-Yin
    Huang, Junwen
    Qiu, Feng
    Qiao, Bin
    Zhang, Yi
    CANCER MEDICINE, 2020, 9 (02): : 640 - 652
  • [22] First-in-human CAR T targets MUC1 transmembrane cleavage product.
    Bamdad, Cynthia
    Stewart, Andrew K.
    Huang, Pengyu
    Smagghe, Benoit J.
    Moe, Scott T.
    Swanson, Tyler E.
    Jeon, Thomas G.
    Page, Danica M.
    Grant, Trevor J.
    Specht, Jennifer M.
    CANCER RESEARCH, 2021, 81 (13)
  • [23] Modulating MUC1 Function on T Cells
    Erick, Timothy K.
    Mukherjee, Pinku
    TRENDS IN IMMUNOLOGY, 2019, 40 (11) : 980 - 983
  • [24] Novel CAR T for solid tumors targets transmembrane cleavage product, called MUC1*, not full-length MUC1.
    Bamdad, Cynthia C.
    Stewart, Andrew K.
    Smagghe, Benoit J.
    Glennie, Nelson D.
    Huang, Pengyu
    Deary, Luke T.
    Swanson, Tyler E.
    Hanahoe, Erin K.
    Mathavan, Ketan K.
    Grant, Trevor J.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 63 - 64
  • [25] First-In-Human CAR T for Solid Tumors Targets the MUC1 Transmembrane Cleavage Product
    Bamdad, Cynthia C.
    Stewart, Andrew K.
    Smagghe, Benoit J.
    Glennie, Nelson D.
    Huang, Pengyu
    Moe, Scott T.
    Swanson, Tyler E.
    Jeon, Thomas G.
    MOLECULAR THERAPY, 2019, 27 (04) : 177 - 177
  • [26] FIRST-IN-HUMAN CAR T TARGETS CLEAVED MUC1, THE GROWTH FACTOR RECEPTOR FORM
    Smagghe, Benoit
    Stewart, Andrew
    Huang, Pengyu
    Swanson, Tyler
    Page, Danica
    Carter, Mark
    Grant, Trevor
    Specht, Jennifer
    Bamdad, Cynthia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A56 - A57
  • [27] First-in-human CAR T for solid tumors targets the MUC1 transmembrane cleavage product
    Bamdad, Cynthia C.
    Glennie, Nelson D.
    Stewart, Andrew K.
    Huang, Pengyu
    Smagghe, Benoit J.
    Swanson, Tyler E.
    Hanahoe, Erin K.
    Riley, Gregory L.
    CANCER RESEARCH, 2019, 79 (13)
  • [28] First-in-human CAR T for solid tumors targets the MUC1 transmembrane cleavage product
    Bamdad, Cynthia C.
    Stewart, Andrew K.
    Huang, Pengyu
    Smagghe, Benoit J.
    Moe, Scott T.
    Swanson, Tyler E.
    Jeon, Thomas G.
    Page, Danica M.
    CANCER RESEARCH, 2020, 80 (04)
  • [29] Doxorubicin-loaded Micelle Targeting MUC1: A Potential Therapeutic for MUC1 Triple Negative Breast Cancer Treatment
    Khondee, Supang
    Chittasupho, Chuda
    Tima, Singkome
    Anuchapreeda, Songyot
    CURRENT DRUG DELIVERY, 2018, 15 (03) : 406 - 416
  • [30] FIRST-IN-HUMAN CAR T FOR SOLID TUMORS TARGETS THE MUC1 TRANSMEMBRANE CLEAVAGE PRODUCT
    Bamdad, C.
    Stewart, A. K.
    Smagghe, B. J.
    Glennie, N. D.
    Huang, P.
    Moe, S.
    Swanson, T.
    Jeon, T.
    CYTOTHERAPY, 2019, 21 (05) : S9 - S9
12345